Cell Division Calculators
0 calculators tagged with “Cell Division”
All Calculators
No calculators found for this topic.
Cell Cycle Phases
- G1 (Gap 1): Cell growth; protein synthesis; preparing for DNA replication; R point (restriction point) at G1/S — irreversible commitment to division
- S phase: DNA replication — each chromosome duplicated; DNA content doubles (2N → 4N)
- G2: Additional growth; repair of replication errors; preparation for mitosis
- M phase (mitosis + cytokinesis): Nuclear division followed by cytoplasmic division → 2 daughter cells
- G0: Quiescent state; many differentiated cells exit the cycle and enter G0; some cells permanently in G0 (neurons, cardiomyocytes)
Cell Cycle Checkpoints
G1/S checkpoint (restriction point): CDK4/6-cyclin D → phosphorylates Rb → releases E2F → S phase entry. Regulated by p16, p21, p53 tumor suppressors. G2/M checkpoint: CDK1-cyclin B (MPF) → triggers mitosis entry. DNA damage → ATM/ATR → Chk1/2 → blocks CDK1. Spindle assembly checkpoint (SAC): Mad1/Mad2 → inhibits APC/C → prevents premature anaphase.
Cytokinesis
Animal cells: actin-myosin cleavage furrow. Plant cells: phragmoplast → cell plate formation by vesicle fusion → new cell wall deposited.
Glossary
Frequently Asked Questions
The cell cycle is the sequence of events leading from one cell division to the next: G1 (Gap 1): cell grows; organelles duplicate; metabolic preparation; R point — if conditions are favorable, the cell commits irreversibly to divide. S phase: DNA synthesis — each chromosome is replicated; DNA content doubles (2N → 4N DNA content). G2 (Gap 2): additional growth; quality control; repair of S-phase errors; preparation of mitotic spindle components. M phase: mitosis (nuclear division) + cytokinesis (cytoplasmic division) → two daughter cells, each with 2N DNA. G0: quiescent state; some cells exit the cycle (differentiated neurons, muscle) and may permanently or transiently stop dividing.
Checkpoints halt cell cycle progression when conditions are not optimal: G1/S checkpoint (restriction point): checks for adequate cell size, growth factors, nutrient availability, and DNA integrity. Cyclins D + CDK4/6 phosphorylate Rb → Rb releases E2F → E2F activates S-phase genes. p53 (tumor suppressor): DNA damage → p53 stabilized → p21 transcribed → CDK2/cyclin E inhibited → cell cycle arrest. G2/M checkpoint: checks for complete DNA replication and DNA damage repair. ATM/ATR kinases → Chk1/Chk2 → phosphorylate CDC25 phosphatase → CDK1-cyclin B (MPF) kept inactive → G2 arrest. Spindle assembly checkpoint: Mad1/Mad2 inhibit APC/C until all kinetochores are attached → prevents premature anaphase.
Animal cell cytokinesis: the cell pinches in half using a contractile ring of actin and myosin II filaments. The cleavage furrow forms at the cell equator (determined by the position of the central spindle). Myosin II moves along actin → ring contracts → furrow deepens → membrane pinches off → two daughter cells. Plant cell cytokinesis: plant cells have rigid cell walls — a contractile ring cannot pull inward. Instead, a phragmoplast forms from remnant spindle microtubules in the midzone. Vesicles containing cell wall materials (pectin, hemicellulose, cellulose synthase) from the Golgi travel along the phragmoplast. Vesicles fuse to form the cell plate → grows outward to the existing cell wall → divides the cell. A new plasma membrane and cell wall separate the two daughter cells.
Cancer arises from accumulation of mutations in cell cycle regulators: Oncogenes (tumor-promoting): RAS mutations → constitutive growth signaling; CCND1 (cyclin D1) amplification → overrides G1 checkpoint; MYC amplification → promotes S-phase entry. Tumor suppressors (growth-restraining): p53 (mutated in ~50% of cancers) → cannot arrest cells at G1/S or trigger apoptosis. Rb mutations (retinoblastoma gene) → E2F always active → cells bypass G1 checkpoint. CDKN2A (p16) deletion → CDK4/6 unregulated. Consequences: cells divide excessively; ignore DNA damage signals; accumulate more mutations; escape apoptosis. Targeting cell cycle: CDK4/6 inhibitors (palbociclib, ribociclib) used in breast cancer; ATR/CHK1 inhibitors in DNA damage-sensitive cancers.